MetaVia Inc. (MTVA)

NASDAQ: MTVA · Real-Time Price · USD

1.600

-0.160 (-9.09%)

At close: Dec 20, 2024, 4:00 PM

1.620

+0.020 (1.26%)

After-hours: Dec 20, 2024, 7:32 PM EST

MetaVia Employees

MetaVia had 8 employees as of December 31, 2023. The number of employees increased by 6 or 300.00% compared to the previous year.

Employees

8

Change (1Y)

6

Growth (1Y)

300.00%

Revenue / Employee

n/a

Profits / Employee

-$3,466,625

Market Cap

13.79M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	8	6	300.00%
Dec 31, 2022	2	-3	-60.00%
Dec 31, 2021	5	-2	-28.57%
Dec 31, 2020	7	-5	-41.67%
Dec 31, 2019	12	-	-

Related Stocks

Company Name	Employees
ProPhase Labs	113
Lifeward	108
ImmunoPrecise Antibodies	101
BioXcel Therapeutics	74
Innovative Eyewear	11
Acurx Pharmaceuticals	4

Employee Rankings

MTVA News

4 weeks ago - NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones with Name Change to MetaVia - Reflecting the Company's Focus on Cardiometabolic Diseases - PRNewsWire
5 weeks ago - NeuroBo Pharmaceuticals to Participate in Investor Conferences in November - PRNewsWire
6 weeks ago - NeuroBo Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
6 weeks ago - NeuroBo Pharmaceuticals Completes Last Patient Last Visit in Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH - PRNewsWire
2 months ago - NeuroBo Pharmaceuticals to Participate in Investor Conferences in October - PRNewsWire
2 months ago - NeuroBo Pharmaceuticals Announces Positive Top-Line Data From the SAD Part 1 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity - PRNewsWire
3 months ago - NeuroBo to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - PRNewsWire
4 months ago - NeuroBo Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire